We provide the latest news
from the world of economics and finance
(RTTNews) - CytoSorbents Corp. (CTSO), a company focused on blood purification technology, on Thursday announced the launch and immediate availability of its PuriFi hemoperfusion machine in the European Union.
This follows necessary approval and certification under the EU Medical Device Regulation.
This blood pump enables an easy and rapid way to administer CytoSorbents' leading CytoSorb blood purification cartridge for critically ill and cardiac surgery patients.
PuriFi is also expected to increase the demand and sales of the cartridge for critically ill patients in the EU.
The PuriFi peristaltic blood pump features differentiating innovation that separate it from other standard hemoperfusion pumps including a pre-assembled adult and pediatric blood line kit, auto-priming, an auto-leveling bubble catcher, an intuitive touchscreen graphical user interface with a step-by-step user-friendly set-up guide, optional blood warming, and a rapid 10-minute set-up time.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2024 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.